<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">There are some medical conditions, which are being treated by ACE inhibitors and angiotensin II type-I receptor blockers, such as type-1 and type-2 diabetes and hypertension that result in the increased expression of ACE2 [
 <xref ref-type="bibr" rid="CR3">3</xref>]. It was hypothesised that treatment with ACE2-stimulating drugs may facilitate the infection with COVID-19 virus and increase the risk of developing severe fatal COVID-19 viral infection [
 <xref ref-type="bibr" rid="CR4">4</xref>]. The ACE2 gene polymorphisms might play important role in the binding of viral spike protein to cell membrane in turn COVID-19 viral infection. It suggests that the recovery of an individual is based on both therapy and ACE2 polymorphism.
</p>
